Antipsychotics in child and adolescent patients with major depressive disorder: A retrospective analysis of prescribing patterns

Antipsychotics in child and adolescent patients with major depressive disorder: A retrospective analysis of prescribing patterns

Introduction Depression rates in children/adolescents in the United States have increased in the last 10 years. Fluoxetine and escitalopram are the only 2 antidepressants approved for the treatment of major depression disorder (MDD) in children/adolescents. In adults, some antipsychotics are approve...

Full description

Bibliographic Details
Main Authors: Danielle Dauchot, PharmD, Suzanne Rettey, PharmD, MPA, BCPP, Brittany L. Melton, PharmD, PhD, Karen E. Moeller, PharmD, BCPP
Format: Article
Language:English
Published: American Association of Psychiatric Pharmacists 2024-02-01
Series:Mental Health Clinician
Subjects:
psychiatry
children
adolescents
antipsychotic
augmentation
mdd
Online Access:https://theijpt.org/doi/pdf/10.9740/mhc.2024.02.010

Internet

https://theijpt.org/doi/pdf/10.9740/mhc.2024.02.010

Similar Items